Frontlight ResearchEarly access
Glioblastoma trials in Israel
1 of 1 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleCrizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
- Where
- Ramat Gan
- Age
- 18 years and over
- People
- 33
- Run by
- Sheba Medical Center
See details and how to joinNCT05909618